整合WGNCA和PPI网络鉴定口腔鳞状细胞癌的关键基因

doi:10.19438/j.cjoms.2024.02.003

中国口腔颌面外科杂志 ›› 2024, Vol. 22 ›› Issue (2): 128-136.doi: 10.19438/j.cjoms.2024.02.003

整合WGNCA和PPI网络鉴定口腔鳞状细胞癌的关键基因

李锦存¹, 翟堃¹, 胡晨¹, 刘絮影¹, 马兴平², 马坚^1,3

1.宁夏医科大学口腔医学院,宁夏银川 750004;
2.吴忠同心县人民医院,宁夏吴忠 751300;
3.宁夏医科大学口腔医学院颅颌面畸形重点实验室,宁夏银川 750001

收稿日期:2023-08-08 修回日期:2023-11-03 发布日期:2024-03-27
通讯作者: 马坚,E-mail: majianhs310@163.com
作者简介:李锦存（1995-）,男,在读硕士研究生,住院医师,E-mail: 1443216409@qq.com
基金资助:
宁夏自然科学基金（2020AAC03413、2021AAC03377、2021AAC03357、2022AAC03473）; 宁夏医科大学口腔医学院一流学科二期建设项目（0019110104）

Integration of WGNCA and PPI networks to identify key genes for oral squamous cell carcinoma

LI Jin-cun¹, ZHAI Kun¹, HU Chen¹, LIU Xu-ying¹, MA Xing-ping², MA Jian^1,3

1. School of Stomatology, Ningxia Medical University. Yinchuan750004;
2. Tongxin County People's Hospital of Wuzhong City. Wuzhong751300;
3. Key Laboratory of Craniomaxillofacial Deformities, School of Stomatology, Ningxia Medical University. Yinchuan750001, Ningxia Province, China

Received:2023-08-08 Revised:2023-11-03 Published:2024-03-27

摘要/Abstract

摘要： 目的: 应用生物信息技术筛查与口腔鳞状细胞癌（OSCC）相关的重要生物标志物。方法:从GEO数据库获取OSCC基因表达谱,鉴定出差异表达基因（DEGs）。利用加权基因共表达网络分析（WGCNA）获得与OSCC关系最密切模块中的核心基因并与DEGs取交集。对重叠DEGs进行通路分析及蛋白网络分析（PPI）,以CytoHubba提取候选关键基因,通过生存分析确定关键基因,验证其在OSCC中的表达,进一步探索关键基因在OSCC中与免疫浸润细胞、免疫检查点之间的关系。采用GraphPad Prism 8软件进行统计学分析。结果: 共鉴定出53个共DEGs,富集分析其主要参与细胞外基质、细胞外区域、PI3K-Akt等通路。从PPI网络中鉴定20个候选核心基因,通过生存分析确定5个（SERPINE1、SERPINH1、LAMC2、ITGA5和ITGA3）与OSCC总生存期相关的基因作为关键基因（P<0.05）。通过GEPIA、GSE30784数据从基因水平证明这5个基因在OSCC组织中存在差异表达（P<0.05）,通过HPA数据库发现SERPINE1在OSCC的蛋白水平上不表达,SERPINH1、LAMC2、ITGA5和ITGA3高表达。另外,5个关键基因与CD8⁺T细胞、树突状细胞等免疫浸润细胞和CD276、VEGFA、PDCD1等免疫检查点明显相关(P<0.05)。结论: SERPINE1、SERPINH1、LAMC2、ITGA5、ITGA3可视为OSCC的生物标志物,其为OSCC的诊断、预后及治疗提供了新的视野。

关键词: 加权基因共表达网络分析, 口腔鳞状细胞癌, 生存分析, 关键基因, 免疫浸润

Abstract: PURPOSE: To screen important biomarkers associated with oral squamous cell carcinoma (OSCC) by using bioinformation technology. METHODS: The gene expression profiles of OSCC were obtained from GEO database and differentially expressed genes (DEGs) extracted. WGCNA was used to obtain the core genes in the module with the most significant relationship with OSCC and intersected with DEGs. At the same time, pathway analysis as well as protein network analysis(PPI) were performed. The CytoHubba was used to extract candidate key genes. Secondly, survival analysis was used to identify key genes, and verify expression in OSCC. Furthermore, the association between key genes and immune infiltrating cells and immune checkpoints was explored in OSCC. GraphPad Prism 8 software was used for data analysis. RESULTS: A total of 53 co-expressed DEGs were identified. Enrichment analysis revealed that these genes mainly involved in extracellular matrix, extracellular region, PI3K-Akt and other pathways. Twenty candidate core genes were identified from PPI networks, among which 5 key genes(SERPINE1, SERPINH1, LAMC2, ITGA5 and ITGA3) were identified using survival analysis. GEPIA and GSE30784 showed that these five genes had differential expression in OSCC tissues (P< 0.05). SERPINE1 was not expressed at the protein level of OSCC through HPA database, but SERPINH1, LAMC2, ITGA5 and ITGA3 were highly expressed. They significantly correlated with immune infiltration cells such as CD8⁺ T cells and dendritic cells and immune checkpoints such as CD276, VEGFA, and PDCD1(P< 0.05). CONCLUSIONS: SERPINE1, SERPINH1, LAMC2, ITGA5 and ITGA3 can be used as biomarkers of OSCC, providing new clues for the diagnosis, prognosis and treatment of OSCC.

Key words: Weighted gene co-expression network analysis, Oral squamous cell carcinoma, Survival analysis, Key genes, Immune infiltration

中图分类号:

R739.8

李锦存, 翟堃, 胡晨, 刘絮影, 马兴平, 马坚. 整合WGNCA和PPI网络鉴定口腔鳞状细胞癌的关键基因[J]. 中国口腔颌面外科杂志, 2024, 22(2): 128-136.

LI Jin-cun, ZHAI Kun, HU Chen, LIU Xu-ying, MA Xing-ping, MA Jian. Integration of WGNCA and PPI networks to identify key genes for oral squamous cell carcinoma[J]. China J Oral Maxillofac Surg, 2024, 22(2): 128-136.

参考文献

[1] Mignogna MD, Fedele S, Lo Russo L.The World Cancer Report and the burden of oral cancer[J]. Eur J Cancer Prev, 2004,13(2):139-142.
[2] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(1): 7-30.
[3] Langfelder P, Horvath S.WGCNA: an R package for weighted correlation network analysis[J]. BMC Bioinformatics, 2008, 9: 559.
[4] Zhu YF, Qi M.Expression and prognostic roles of PABPC1 in hepatocellular carcinoma[J]. Int J Surg, 2020, 84: 3-12.
[5] Uhlén M, Björling E, Agaton C, et al.A human protein atlas for normal and cancer tissues based on antibody proteomics[J]. Mol Cell Proteomics, 2005, 4(12): 1920-1932.
[6] Li T, Fu J, Zeng Z, et al.TIMER2.0 for analysis of tumor-infiltrating immune cells[J]. Nucleic Acids Res, 2020, 48(W1): W509-W514.
[7] Azimi F, Scolyer RA, Rumcheva P,et al.Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma[J]. J Clin Oncol, 2012, 30(21):2678-2683.
[8] Mehrotra R,Gupta DK.Exciting new advances in oral cancer diagnosis: avenues to early detection[J]. Head Neck Oncol, 2011, 3: 33.
[9] Di Martino JS, Nobre AR, Mondal C, et al.A tumor-derived type Ⅲ collagen-rich ECM niche regulates tumor cell dormancy[J]. Nat Cancer, 2022. 3(1): 90-107.
[10] Fang M, Yuan J, Peng C, et al.Collagen as a double-edged sword in tumor progression[J]. Tumour Biol, 2014, 35(4): 2871-2882.
[11] Siddhartha R, Garg M.Molecular and clinical insights of matrix metalloproteinases into cancer spread and potential therapeutic interventions[J]. Toxicol Appl Pharmacol, 2021, 426: 115593.
[12] Adeshakin FO, Adeshakin AO, Afolabi LO, et al.Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming[J]. Front Oncol, 2021, 11: 626577.
[13] Sorokin L.The impact of the extracellular matrix on inflammation[J]. Nat Rev Immunol, 2010, 10(10):712-723.
[14] Dhanda J, Triantafyllou A, Liloglou T, et al.SERPINE1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma[J]. Br J Cancer, 2014, 111(11): 2114-2121.
[15] Yu J, Lou Y, Hou M, et al.Circ_0058063 contributes to oral squamous cell carcinoma development by sponging miR-145-5p and upregulating SERPINE1[J]. J Oral Pathol Med, 2022, 51(7): 630-637.
[16] Li X, Wang C, Zhang H, et al.circFNDC3B accelerates vasculature formation and metastasis in oral squamous cell carcinoma[J]. Cancer Res, 2023,83(9):1459-1475.
[17] Tian S, Peng P, Li J, et al.SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway[J]. Aging (Albany NY), 2020, 12(4): 3574-3593.
[18] Wang C, Wang Z, Zhang L, et al.MiR-29c inhibits the metastasis of oral squamous cell carcinoma and promotes its cell cycle arrest by targeting SERPINH1[J]. Ann Transl Med, 2021, 9(18): 1423.
[19] Du J, Zhao Y, Hu D, et al.Silencing of integrin subunit α3 inhibits the proliferation, invasion, migration and autophagy of esophageal squamous cell carcinoma cells[J]. Oncol Lett, 2022, 24(2): 271-282.
[20] Fan QC, Tian H, Wang Y, et al.Integrin-α5 promoted the progression of oral squamous cell carcinoma and modulated PI3K/AKT signaling pathway[J]. Arch Oral Biol, 2019, 101: 85-91.
[21] Zhao C, Shi W, Chen M.Long non-coding RNA BBOX1-antisense RNA 1 enhances cell proliferation and migration and suppresses apoptosis in oral squamous cell carcinoma via the miR-3940-3p/laminin subunit gamma 2 axis[J]. Bioengineered, 2022, 13(4): 11138-11153.
[22] Saeed M, Chen F, Ye J, et al.From design to clinic: engineered nanobiomaterials for immune normalization therapy of cancer[J]. Adv Mater, 2021, 33(30): e2008094.
[23] Zhang C, Zhang G, Sun N, et al.An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma[J]. Signal Transduct Target Ther, 2020, 5(1): 182-192.
[24] Xu X, Zhang L, Qian Y, et al.A SERPINE1-based immune gene signature predicts prognosis and immunotherapy response in gastric cancer[J]. Pharmaceuticals (Basel), 2022, 15(11):1401.
[25] Wang Y, Gu W, Wen W, et al.SERPINH1 is a potential prognostic biomarker and correlated with immune infiltration: a pan-cancer analysis[J]. Front Genet, 2021, 12: 756094.
[26] Li S, Zhang N, Liu S, et al.ITGA5 is a novel oncogenic biomarker and correlates with tumor immune microenvironment in gliomas[J]. Front Oncol, 2022, 12: 844144.
[27] Xiao M, Zhang J, Chen W, et al.M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma[J]. J Exp Clin Cancer Res, 2018, 37(1): 143-158.
[28] Benzon B, Zhao SG, Haffner MC, et al.Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis[J]. Prostate Cancer Prostatic Dis, 2017, 20(1): 28-35.
[29] Cheng R, Chen Y, Zhou H, et al.B7-H3 expression and its correlation with clinicopathologic features, angiogenesis, and prognosis in intrahepatic cholangiocarcinoma[J]. Apmis, 2018, 126(5): 396-402.

整合WGNCA和PPI网络鉴定口腔鳞状细胞癌的关键基因

Integration of WGNCA and PPI networks to identify key genes for oral squamous cell carcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	周鑫霞，刘敬浩，甘桂芳，陈福祥. 鞘氨醇-1-磷酸受体4在口腔鳞状细胞癌中的表达及生物学功能[J]. 中国口腔颌面外科杂志, 2024, 22(1): 10-15.
[2]	韩林孜, 周建华, 董磊, 赵璐, 袁荣涛. 肿瘤相关成纤维细胞对口腔鳞状细胞癌生物学行为影响的研究进展[J]. 中国口腔颌面外科杂志, 2024, 22(1): 84-91.
[3]	曾慧, 江花香, 胡彦昌, 杨丰瑞, 王军. 基于生物信息学分析筛选舌鳞癌的关键基因[J]. 中国口腔颌面外科杂志, 2023, 21(5): 452-460.
[4]	李贵忠, 李洁莹, 周凯, 孟宇翔, 王可心, 葛胜优, 宋凯, 冯元勇, 陶月琴, 展晓红, 尚伟. 淋巴结外扩展对口腔鳞癌患者TNM分期及生存预后的影响[J]. 中国口腔颌面外科杂志, 2023, 21(4): 377-383.
[5]	热孜万姑丽·亚森, 买热拍提·买明, 李晨曦, 龚忠诚. 牙龈卟啉单胞菌促进口腔鳞状细胞癌进展的作用及机制研究进展[J]. 中国口腔颌面外科杂志, 2023, 21(2): 186-190.
[6]	兰嵘, 阮敏, 韩楠男, 王凤. 左下种植修复后发生植体周围鳞状细胞癌1例报告[J]. 中国口腔颌面外科杂志, 2023, 21(2): 203-205.
[7]	苏姿尚, 崔文丽, 张梦云, 姚志涛. 口腔鳞状细胞癌患者颈部淋巴结特征与预后的关系[J]. 中国口腔颌面外科杂志, 2023, 21(1): 41-48.
[8]	顾雨薇, 王凤, 黄伟, 张志勇, 张陈平, 孙坚, 吴轶群. 种植联合血管化髂骨移植重建14例下颌骨缺损的长期疗效观察[J]. 中国口腔颌面外科杂志, 2022, 20(5): 422-428.
[9]	杨慧丽, 王宇帆, 王锋, 沈月洪, 杨宏宇. NLRP1在头颈部鳞癌中的表达及预后意义[J]. 中国口腔颌面外科杂志, 2022, 20(5): 429-436.
[10]	顾雨薇, 王凤, 黄伟, 张志勇, 张陈平, 孙坚, 吴轶群. 种植联合血管化髂骨移植重建14例下颌骨缺损的长期疗效观察[J]. 中国口腔颌面外科杂志, 2022, 20(5): 488-493.
[11]	叶晨, 蔡云, 赵小妹, 张陈平, 赵耐青. 638例舌鳞癌预后及影响因素分析[J]. 中国口腔颌面外科杂志, 2021, 19(5): 449-455.
[12]	陈秀敏, 刘族志, 林建能. 血浆miR-136-5p表达水平对口腔鳞状细胞癌患者预后预测的价值[J]. 中国口腔颌面外科杂志, 2020, 18(6): 526-530.
[13]	梁思源, 赵铜超, 周知航, 琚梧桐, 刘莹, 张志愿, 钟来平. 可利霉素对口腔鳞癌细胞生物学活性的影响[J]. 中国口腔颌面外科杂志, 2020, 18(4): 308-313.
[14]	王锋, 李翔, 王宇帆, 杨宏宇. 环状RNA在口腔鳞状细胞癌中的作用探讨[J]. 中国口腔颌面外科杂志, 2019, 17(6): 496-502.
[15]	李翔, 苏文, 张寒雨, 张璧茹, 杨宏宇. 沉默环状RNA hsa_circ_0006677 表达对口腔鳞状细胞癌迁移及侵袭能力的影响[J]. 中国口腔颌面外科杂志, 2019, 17(4): 289-294.